scholarly journals Diagnosis and Treatment Strategy of Post Operative Chylothorax After Radical Surgery for Esophageal Cancer

Author(s):  
Yoshiyuki Hoya ◽  
Mitsuo Yabe ◽  
Atsushi Watanabe ◽  
Tsuyoshi Hirabayashi ◽  
Shuji Sato ◽  
...  
ORL ro ◽  
2018 ◽  
Vol 2 (39) ◽  
pp. 18
Author(s):  
Daniela Vrînceanu ◽  
Mihai Dumitru ◽  
Bogdan Bănică ◽  
Adriana Nica

2005 ◽  
Vol 38 (1) ◽  
pp. 7-12 ◽  
Author(s):  
Mamoru Uemura ◽  
Yuichiro Doki ◽  
Osamu Ishikawa ◽  
Jun Ueda ◽  
Kouichi Yoshikawa ◽  
...  

2016 ◽  
Vol 23 (S5) ◽  
pp. 841-849 ◽  
Author(s):  
Violante Di Donato ◽  
Michele Carlo Schiavi ◽  
Ilary Ruscito ◽  
Virginia Sibilla Visentin ◽  
Innocenza Palaia ◽  
...  

Esophagus ◽  
2013 ◽  
Vol 10 (3) ◽  
pp. 135-143 ◽  
Author(s):  
Shirou Kuwabara ◽  
Akiko Tonouchi ◽  
Shoichi Manabe ◽  
Natsuru Sudo ◽  
Tomohiro Katada ◽  
...  

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 44-45
Author(s):  
Jie Jiang ◽  
Xiuyi Yu ◽  
Guojun Geng ◽  
Hongming Liu

Abstract Description To The basic operation procedure of esophageal cancer radical surgery. Disclosure All authors have declared no conflicts of interest.


2022 ◽  
pp. 56-60
Author(s):  
E. V. Uvarova ◽  
E. P. Khashchenko ◽  
S. O. Kyurdzidi

This review is addressing an urgent problem of diagnosis and treatment strategy of polycystic ovary syndrome in adolescent girls. We analysed data from modern literary publications on the epidemiology and classification of the disease, as well as the adaptation of general principles for the management of young female patients tailored to their age peculiarities. The effective treatment strategies for adolescent girls with PCOS depending on its type are presented. Today there are several contradictions associated with both the diagnosis and treatment of the disease in the medical community. Thus, the use of the well-known Rotterdam criteria makes it difficult to diagnose PCOS in adolescent girls, since the criteria do not take into account characteristic changes that occur during puberty. Such manifestations as acne, hirsutism, menstrual irregularities, high androgen levels and morphology of polycystic ovaries on pelvic ultrasound imaging should be assessed with due account for age, puberty, hormonal balance with an assessment of the ratio of LH (luteinizing hormone)/FSH (follicle-stimulating hormone) and Free Androgen Index. There is no consensus in the medical community regarding the treatment strategy for PCOS. International communities have identified two main goals in the management of patients: normalization of menstrual function and improvement of the patients’ quality of life by preventing clinical symptoms of hyperandrogenism, and metabolic disorders of hyperplastic processes in target organs.Our analysis of objective scientific data showed that modern monophasic combined oral contraceptives (COCs) supplemented by of a folate component should be used to treat young female patients with PCOS, hyperandrogenism and psychosomatic disorders.


Author(s):  
Lei Wang ◽  
Huiqiong Han ◽  
Zehua Wang ◽  
Litong Shi ◽  
Mei Yang ◽  
...  

Esophageal cancer (EC) is the eighth most common type of cancer and the sixth leading cause of cancer-related deaths worldwide. At present, the clinical treatment for EC is based mainly on radical surgery, chemotherapy, and radiotherapy. However, due to the limited efficacy of conventional treatments and the serious adverse reactions, the outcome is still unsatisfactory (the 5-year survival rate for patients is less than 25%). Thus, it is extremely important and urgent to identify new therapeutic targets. The concept of tumor microenvironment (TME) has attracted increased attention since it was proposed. Recent studies have shown that TME is an important therapeutic target for EC. Microenvironment-targeting therapies such as immunotherapy and antiangiogenic therapy have played an indispensable role in prolonging survival and improving the prognosis of patients with EC. In addition, many new drugs and therapies that have been developed to target microenvironment may become treatment options in the future. We summarize the microenvironment of EC and the latest advances in microenvironment-targeting therapies in this review.


1988 ◽  
pp. 375-380 ◽  
Author(s):  
M. Endo ◽  
H. Ide ◽  
K. Yoshino ◽  
M. Yoshida

Sign in / Sign up

Export Citation Format

Share Document